Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10046512HBVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30086165HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS30037769HIVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007173HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20007241HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS20045839HPVENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TVIS44041826HTLV-1ENSG00000184984.10protein_codingCHRM5NoNo1133P08912
Q8IVW0
TCGA Plot Options
Drug Information
GeneCHRM5
DrugBank IDDB11235
Drug NameThonzylamine
Target IDBE0000247
UniProt IDP08912
Regulation Typeantagonist
PubMed IDs18858080; 18888474
CitationsSCUDI JV, REINHARD JF, DREYER NB: Pharmacologic characteristics of neohetramine, a new antihistaminic drug. J Allergy. 1948 May;19(3):184-99.@@AARON TH, CRIEP LH: Neohetramine and thephorin; two new antihistaminic drugs. Can Med Assoc J. 1948 Nov;59(5):438-41.
GroupsApproved
Direct ClassificationAnisoles
SMILESCOC1=CC=C(CN(CCN(C)C)C2=NC=CC=N2)C=C1
PathwaysThonzylamine H1-Antihistamine Action
PharmGKB
ChEMBLCHEMBL1623738